Latest filing published 14 Nov 2023 for Tabula Rasa HealthCare, Inc., €65.3M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Indaba Capital Management, L.P. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Benefitfocus, Inc., Tabula Rasa HealthCare, Inc. and Unwired Planet, Inc. The record holds 33 filings, for trades running from 31 January 2014 to 3 November 2023.
On the open market, the record shows 22 purchases worth €10.6M and 1 sale worth €4.4M. Netting one side against the other leaves €6.2M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants.
A typical purchase (the median) is worth €262k. None of the 16 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 14 November 2023, the filings show a transaction worth €65.3M in Tabula Rasa HealthCare, Inc. The clock since the last published purchase (27 July 2022) now reads 1,550 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations